Regulation of Telomerase Alternative Splicing: A Target for Chemotherapy

Cell Reports

Volumn 3, Issue 4, 2013, Pages 1028-1035

  Wong, Mandy S ^a   Chen, Ling ^a   Foster, Christopher ^b   Kainthla, Radhika ^a   Shay, Jerry W ^a   Wright, Woodring E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Sierra Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ENZYME INHIBITION; EXON SKIPPING; HTERT MINIGENE; INTRON; PRIORITY JOURNAL;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE, TUMOR; EXONS; HCT116 CELLS; HEK293 CELLS; HELA CELLS; HT29 CELLS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; TELOMERASE;

MAMMALIA;

EID: 84876994472     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.03.011     Document Type: Article

References (38)

1. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
2. Bryan T.M., Englezou A., Dalla-Pozza L., Dunham M.A., Reddel R.R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 1997, 3:1271-1274.
3. Chen H., Li Y., Tollefsbol T.O. Strategies targeting telomerase inhibition. Mol. Biotechnol. 2009, 41:194-199.
4. Cohen S.B., Graham M.E., Lovrecz G.O., Bache N., Robinson P.J., Reddel R.R. Protein composition of catalytically active human telomerase from immortal cells. Science 2007, 315:1850-1853.
5. Daniel M., Peek G.W., Tollefsbol T.O. Regulation of the human catalytic subunit of telomerase (hTERT). Gene 2012, 498:135-146.
6. Dominski Z., Kole R. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 1993, 90:8673-8677.
7. Fajkus J., Sykorova D., Leitch A.R. Telomeres in evolution and evolution of telomeres. Chromosome Res. 2005, 13:469-479.
8. Friedman K.J., Kole J., Cohn J.A., Knowles M.R., Silverman L.M., Kole R. Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides. J. Biol. Chem. 1999, 274:36193-36199.
9. Garcia C.K., Wright W.E., Shay J.W. Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res. 2007, 35:7406-7416.
10. Gomes N.M., Ryder O.A., Houck M.L., Charter S.J., Walker W., Forsyth N.R., Austad S.N., Venditti C., Pagel M., Shay J.W., Wright W.E. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination. Aging Cell 2011, 10:761-768.
11. Greider C.W. Telomeres, telomerase and senescence. Bioessays 1990, 12:363-369.
12. Harley C.B. Telomere loss: mitotic clock or genetic time bomb?. Mutat. Res. 1991, 256:271-282.
13. Joseph I., Tressler R., Bassett E., Harley C., Buseman C.M., Pattamatta P., Wright W.E., Shay J.W., Go N.F. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. Cancer Res. 2010, 70:9494-9504.
14. Kilian A., Bowtell D.D., Abud H.E., Hime G.R., Venter D.J., Keese P.K., Duncan E.L., Reddel R.R., Jefferson R.A. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 1997, 6:2011-2019.
15. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
16. Kole R., Krainer A.R., Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat. Rev. Drug Discov. 2012, 11:125-140.
17. Leem S.H., Londoño-Vallejo J.A., Kim J.H., Bui H., Tubacher E., Solomon G., Park J.E., Horikawa I., Kouprina N., Barrett J.C., Larionov V. The human telomerase gene: complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions. Oncogene 2002, 21:769-777.
18. Levy M.Z., Allsopp R.C., Futcher A.B., Greider C.W., Harley C.B. Telomere end-replication problem and cell aging. J. Mol. Biol. 1992, 225:951-960.
19. Llorian M., Schwartz S., Clark T.A., Hollander D., Tan L.Y., Spellman R., Gordon A., Schweitzer A.C., de la Grange P., Ast G., Smith C.W. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat. Struct. Mol. Biol. 2010, 17:1114-1123.
20. Marian C.O., Cho S.K., McEllin B.M., Maher E.A., Hatanpaa K.J., Madden C.J., Mickey B.E., Wright W.E., Shay J.W., Bachoo R.M. The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth. Clin. Cancer Res. 2010, 16:154-163.
21. Morales C.P., Holt S.E., Ouellette M., Kaur K.J., Yan Y., Wilson K.S., White M.A., Wright W.E., Shay J.W. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 1999, 21:115-118.
22. Mulders S.A., van den Broek W.J., Wheeler T.M., Croes H.J., van Kuik-Romeijn P., de Kimpe S.J., Furling D., Platenburg G.J., Gourdon G., Thornton C.A., et al. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc. Natl. Acad. Sci. USA 2009, 106:13915-13920.
23. Nosek J., Kosa P., Tomaska L. One the origin of telomeres: a glimpse at the pre-telomerase world. Bioessays 2006, 28:182-190.
24. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 1973, 41:181-190.
25. Parra M.K., Gallagher T.L., Amacher S.L., Mohandas N., Conboy J.G. Deep intron elements mediate nested splicing events at consecutive AG dinucleotides to regulate alternative 3' splice site choice in vertebrate 4.1 genes. Mol. Cell. Biol. 2012, 32:2044-2053.
26. Pros E., Fernández-Rodríguez J., Canet B., Benito L., Sánchez A., Benavides A., Ramos F.J., López-Ariztegui M.A., Capellá G., Blanco I., et al. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations. Hum. Mutat. 2009, 30:454-462.
27. Saebøe-Larssen S., Fossberg E., Gaudernack G. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol. Biol. 2006, 7:26.
28. Salem I.H., Hsairi I., Mezghani N., Kenoun H., Triki C., Fakhfakh F. CAPN3 mRNA processing alteration caused by splicing mutation associated with novel genomic rearrangement of Alu elements. J. Hum. Genet. 2012, 57:92-100.
29. Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer 1997, 33:787-791.
30. Ulaner G.A., Hu J.F., Vu T.H., Giudice L.C., Hoffman A.R. Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int. J. Cancer 2001, 91:644-649.
31. Varani L., Hasegawa M., Spillantini M.G., Smith M.J., Murrell J.R., Ghetti B., Klug A., Goedert M., Varani G. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc. Natl. Acad. Sci. USA 1999, 96:8229-8234.
32. Watson J.D. Origin of concatameric T4 DNA. Nat. New Biol. 1972, 239:197-201.
33. Wright W.E., Brasiskyte D., Piatyszek M.A., Shay J.W. Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J. 1996, 15:1734-1741.
34. Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., Shay J.W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 1996, 18:173-179.
35. Yeo G.W., Coufal N.G., Liang T.Y., Peng G.E., Fu X.D., Gage F.H. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol. 2009, 16:130-137.
36. Yi X., White D.M., Aisner D.L., Baur J.A., Wright W.E., Shay J.W. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2000, 2:433-440.
37. Yi X., Shay J.W., Wright W.E. Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res. 2001, 29:4818-4825.
38. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31:3406-3415.